Stada Arzneimi Namen (STDAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 312,114 | 207,783 | 351,504 | 366,738 | N/A |
| Depreciation Amortization | 380,098 | 280,137 | 254,241 | 175,732 | N/A |
| Accounts receivable | -55,831 | -131,473 | -67,529 | 573 | N/A |
| Accounts payable and accrued liabilities | 40,805 | 58,328 | 95,726 | -60,835 | N/A |
| Other Working Capital | -355,297 | -584,337 | -326,601 | -342,703 | N/A |
| Other Operating Activity | 385,894 | 633,210 | 190,028 | 238,755 | 0 |
| Operating Cash Flow | $707,784 | $463,648 | $497,370 | $378,260 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -90,408 | -68,434 | -85,079 | -54,808 | N/A |
| Net Acquisitions | 6,018 | -835,082 | -51,111 | 30,009 | N/A |
| Purchase Of Investment | -1,183 | -1,294 | -5,045 | -331 | N/A |
| Purchase Sale Intangibles | -278,609 | -494,635 | -181,038 | -329,506 | N/A |
| Other Investing Activity | -278,609 | -494,899 | -155,552 | -329,506 | 0 |
| Investing Cash Flow | $-364,182 | $-1,399,709 | $-296,787 | $-354,635 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 616,358 | 2,555,973 | 14,454 | 1,115,571 | N/A |
| Debt Repayment | -278,066 | -921,554 | -170,344 | -969,463 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 2 | N/A |
| Dividend Paid | -209,616 | -420,964 | -169,356 | -10,563 | N/A |
| Other Financing Activity | -170,456 | -200,796 | -29,454 | -41,391 | 0 |
| Financing Cash Flow | $-41,780 | $1,012,659 | $-354,701 | $94,156 | $N/A |
| Exchange Rate Effect | 5,241 | 2,000 | -168 | 1,074 | N/A |
| Beginning Cash Position | 314,706 | 235,358 | 385,049 | 287,213 | N/A |
| End Cash Position | 622,881 | 303,853 | 230,764 | 406,021 | N/A |
| Net Cash Flow | $308,175 | $68,495 | $-154,286 | $118,807 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 707,784 | 463,648 | 497,370 | 378,260 | N/A |
| Capital Expenditure | -93,035 | -73,943 | -92,644 | -56,762 | N/A |
| Free Cash Flow | 614,748 | 389,705 | 404,725 | 321,498 | 0 |